View News Comments
 |
 |
Link Information - Click to View
Rate Story:
Total votes: 0
Biotech firms face cash shortages
Almost 40% of small and midsize public biotechnology companies in the U.S. are in danger of running out of cash within a year and government help is needed to encourage investment, industry leaders say.
Almost 40% of small and midsize public biotechnology companies in the U.S. are in danger of running out of cash within a year and government help is needed to encourage investment, industry leaders say.
Source: USA Today
Posted on: Monday, Nov 24, 2008, 8:56am
Views: 1672
Posted on: Monday, Nov 24, 2008, 8:56am
Views: 1672
 |
 |
Add Comment?
 |
 |
Friends